Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

Author： Bosse Kristopher R.   Maris John M.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|122|1|20-33

ISSN： 0008-543X

Source： Cancer, Vol.122, Iss.1, 2016-01, pp. : 20-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer genome sequencing and functional genomics: from translational to clinical medicine

By Roukos Dimitrios H  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1371-1374

Future Medicine

Access to resources Recommend Favorite

Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations

By  

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2452-2463

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Genomics Conference: From Identifying Proteins to Faster Drug Discovery

By Palfreyman M.G.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. : 1201-1207

Informa Healthcare

Access to resources Recommend Favorite

A Systems Biology Approach for Identifying Novel Pathway Regulators in eQTL Mapping

By Li Shaoyu  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 2, 2010-03 ,pp. : 373-400

Taylor & Francis Ltd

Access to resources Recommend Favorite

From Genomic Imprinting to Developmental Physiology: Identifying Stepping Stones

By  

Current Pharmacogenomics, Vol. 2, Iss. 3, 2004-01 ,pp. : 233-242

Bentham Science Publishers

Access to resources Recommend Favorite